Glenn Cooper (born January 8, 1953) is an American author and physician best known for being an internationally best selling thriller writer.

[1][8][9][10] He completed an internship and residency in internal medicine at the Beth Israel Deaconess Medical Center and a fellowship in infectious diseases at the Massachusetts General Hospital in Boston.

[1] He served as an emergency physician at the Khao-I-Dang Refugee Camp in Thailand, a position sponsored by the International Rescue Committee, and at the Hôpital Albert Schweitzer in Haiti.

[4][1] He held several research, clinical and regulatory positions at Lilly in the United States and England before joining the biotechnology company, Sphinx Pharmaceuticals, Inc. in Durham, North Carolina in 1990 as executive vice president and chief operating officer.

Then, in 1993, he joined Interneuron Pharmaceuticals in Lexington, Massachusetts, Progenitor’s parent company, as chairman and chief executive officer.

[1][13][14][15] While at Indevus, Cooper oversaw the FDA approval and commercial introduction of several drugs for urological and endocrinological conditions.

[2] In addition, each of his books spotlights a large philosophical theme: fate and predestination, the nature of evil, conceptions of the afterlife, resurrection, and the interface between science and faith.